Clinical Trials
Study Title:
A Phase 1b/2 Study of HCW9218, a Bifunctional TGF ß Antagonist/IL 15 Protein Complex, for Advanced Pancreatic Cancer
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Albert Lockhart, at lockhara@musc.edu.
Study Coordinator, Bria Sanders, at sandebri@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |